Mainland China

NMPA Clears IND for First T-Cell Receptor (TCR) T Cell Therapy to Treat Hepatitis B virus (HBV) associated hepatocellular carcinoma (HCC)

SINGAPORE, March 11, 2022 /PRNewswire/ -- Singapore-based SCG Cell Therapy Pte Ltd ("SCG"), a leading biotechnology company, today announced that the China National Medical Products Administration (NMPA) has cleared its Investigational New Drug (IND) application for SCG101, the company's first T-...

2022-03-11 21:07 4757

Angel Yeast Steps Up Low-Carbon Measures in Green Push to Promote Global Sustainable Development

YICHANG, China, March 11, 2022 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast" or "the Company", 600298.SH), a listed global yeast and yeast extract manufacturer, has reached another recognition milestone for its green push towards the goal of carbon-neutrality ...

2022-03-11 20:30 5200

Ping An Launches Home-Based Elderlycare Service to Pursue "Finance + Elderlycare" Business Strategy

HONG KONG and SHANGHAI, March 11, 2022 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) announced that subsidiaryPing An Life has launched an elderly home care service. Building on the strength ofPing An's healthcare ecosy...

2022-03-11 14:47 3615

Prototype enables new synergy - how Artosyn helps their customers succeed

HSINCHU, March 11, 2022 /PRNewswire/ -- Artosyn Microelectronics, a leading provider of AI SoCs for drones and other sophisticated applications finds itself at the intersection of hardware architecture and software development. "Our customers are advancing the state of AI programming every day," ...

2022-03-11 09:00 2280

Yum China Provides Update on Status under Holding Foreign Companies Accountable Act

SHANGHAI, March 11, 2022 /PRNewswire/ – Yum China Holdings, Inc. (the "Company" or "Yum China") (NYSE: YUMC and HKEX: 9987) today provided an update on its status under the Holding Foreign Companies Accountable Act (the "Act"). On March 8, 2022, as expected in its implementation of the Act, the U...

2022-03-11 08:15 4091

Risen Energy wins bid to supply 210mm 650W+ PV modules to Sinopec's green hydrogen demonstration project in Xinjiang

NINGBO, China, March 11, 2022 /PRNewswire/ -- Risen Energy Co., Ltd., a leading solar module manufacturer inChina, announced that it has won the bid to supply TITAN 650W PV modules to Sinopec's green hydrogen demonstration project in Kuqa County, Xinjiang. The 361 MW project, once completed, is e...

2022-03-11 02:00 3178

Everest Medicines Announces that Licensing Partner Venatorx Pharmaceuticals Reports Positive Results from Pivotal Phase 3 Cefepime-Taniborbactam Trial

SHANGHAI, March 10, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its licensing partner, Venatorx Pharmaceuticals, reported positive results from its pivotal Phase 3 study, CERTAIN-1 (Cefepime Rescue with Taniborbactam in cUTI), evaluating cefepime-taniborbactam, an in...

2022-03-10 19:05 2497

Infosys Becomes Digital Innovation Partner for International Tennis Hall of Fame and Title Sponsor of the Hall of Fame Open

Strategic collaboration to bring technology expertise to reimagine fan experiences and preserve tennis heritage at the historic venue where the first U.S. National Championships were hosted in 1881 NEWPORT, R.I., March 10, 2022 /PRNewswire/ -- Infosys  (NSE: INFY) (BSE:...

2022-03-10 18:49 2450

World Leaders in the Digital Economy Convene in Hangzhou to Discuss New Opportunities

HANGZHOU, China, March 10, 2022 /PRNewswire/ -- Global Digital Ecosystem Conference 2022, the first such conference of its kind andone of the theme forums of the world's first Global Digital Trade Expo (GDTE), will be held in Hangzhou, Zhejiang province. The event is designed to promote the quali...

2022-03-10 12:48 2882

Everlife acquires Research Instruments Group and other laboratory suppliers to boost presence in strategic life sciences and clinical diagnostics segments in South East Asia

SINGAPORE, March 10, 2022 /PRNewswire/ -- Everlife Holdings Pte Ltd ("Everlife"), a leading market access and distribution company inIndia and South East Asia, has announced the completion of its acquisition of Research Instruments Group ("RI"), a leading provider of scientific and laboratory in...

2022-03-10 12:00 3064

Nature Research Custom Media: SHAPING THE FUTURE OF OMICS FOR ALL

SHENZHEN, China, March 10, 2022 /PRNewswire/ -- Nature Research Custom Media published a feature story "Shaping the Future of Omics for All" about BGI Genomics, showcasing how the world-leading genome sequencing organization cultivates and leads the gene sequencing service industry and brings ...

2022-03-10 10:05 2188

Antengene Announces IND Approval in China for the Phase I Study of ATG-101 (PD-L1/4-1BB Bispecific Antibody) for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma

-  The novel bispecific antibody ATG-101 is Antengene's first in house developed molecule with global rights. -  This approval in China marks the third regulatory clearance granted to ATG-101 globally. -  Upon receiving clearances in Australia and the U.S. in 2021, the Phase I study of ATG-101 ...

2022-03-10 08:52 2155

Transcenta Presented Safety / Tolerability and Preliminary Anti-tumor Activity Data in Gastric and Pancreatic Cancers of TST001 Monotherapy from China Phase I Clinical Trial at the 2022 International Gastric Cancer Congress

SUZHOU, China, March 10, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that Transcenta has ...

2022-03-10 08:30 2951

Two New Models of the World's First Evolvable Super SUV HiPhi X Now Available

SHANGHAI, March 9, 2022 /PRNewswire/ -- This month, industry-leading new mobility and intelligent driving research company, Human Horizons, released details about two new models of the HiPhi X Super SUV. Offering technological sophistication and luxury comfort, the 6-seater Creative Extended Rang...

2022-03-09 22:03 2637

New Tough Off-road Contender--GWM TANK300 Arrives Now

BAODING, China, March 9, 2022 /PRNewswire/ -- Recently, according to the 2021 sales report of GWM, GWM TANK300 has an outstanding market share, accounting for more than 50% of the tough off-road market inChina.

2022-03-09 21:59 8554

Xinhua Silk Road: 800 Ankai natural gas buses exported to Mexico for operation

BEIJING, March 9, 2022 /PRNewswire/ -- Anhui Ankai Automobile Co., Ltd., a leading automaker in eastChina's Anhui Province, held a ceremony on Tuesday to mark the export of 800 natural gas buses toMexico. Photo taken on March 8 shows the departure ...

2022-03-09 21:03 2211

Pudu Robotics Helps Hong Kong Combat Covid-19 Pandemic

The firm once again participates in the fight against the pandemic by donating robots that support contactless delivery and automatic disinfection SHENZHEN, China, March 9, 2022 /PRNewswire/ -- Pudu Robotics , the global leader in commercial service robots, has dona...

2022-03-09 20:00 2325

Antengene Announces Five Upcoming Presentations at the 2022 American Association for Cancer Research Annual Meeting

* Posters Showcase Early-Stage Clinical and Preclinical Pipeline. * Focus on ATG-037, ATG-018, ATG-022, ATG-012 and ATG-008. SHANGHAI and HONG KONG, March 9, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company ...

2022-03-09 20:00 2183

Bilibili-Produced Short Series, Night Cat Express: Night Dream Selected for 2022 CANNESERIES

SHANGHAI, March 9, 2022 /PRNewswire/ -- On March 9, CANNESERIES announced that short seriesNight Cat Express: Night Dream produced by Bilibili, the leading video community for young gener...

2022-03-09 19:35 1888

Antengene Announces XPOVIO® Approved by the TGA in Australia for the Treatment of Relapsed and/or Refractory Multiple Myeloma and Triple Class-Refractory Multiple Myeloma

-  XPOVIO®, in combination with bortezomib and dexamethasone (XBd), gives patients with relapsed and/or refractory multiple myeloma, a new treatment option. -  XPOVIO®, in combination with dexamethasone (Xd), gives patients with triple class refractory multiple myeloma, a new treatment option.  ...

2022-03-09 19:08 2124
1 ... 372373374375376377378 ... 811